# ZERBAXA
> **NDA206829** · New Drug Application · Sponsor: CUBIST PHARMS LLC · Approved 2014-12-19
## Drug
- **FDA Application Number:** NDA206829
- **Application type:** New Drug Application
- **Brand name:** ZERBAXA
- **Generic name:** CEFTOLOZANE AND TAZOBACTAM
- **Active ingredients:** CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CUBIST PHARMS LLC
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2014-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206829)
---
*MORVS · CC0 1.0*